Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo
NCT05812079 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 33
Last updated 2024-02-08
Summary
Insulin like growth factor has a protective role on melanocytes against the oxidative stress. The aim is to investigate this effect in vitiligo patients.
Conditions
- Vitiligo
Interventions
- DIAGNOSTIC_TEST
-
skin biopsy examined by ELISA technique
skin biopsy examined by ELISA technique
Sponsors & Collaborators
-
Cairo University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-01
- Primary Completion
- 2024-10-01
- Completion
- 2024-10-01
More Related Trials
-
Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients
NCT06261073 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions
NCT05927272 ·Status: RECRUITING ·Phase: NA
-
E-cadherin and Integrin Alpha v Beta 1 in Vitiligo
NCT05287776 ·Status: UNKNOWN ·Phase: NA
-
Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo
NCT03371758 ·Status: UNKNOWN ·Phase: NA
-
Expression of Erythroid Differentiation Regulator 1 (Erdr1) in Vitiligo
NCT03377998 ·Status: UNKNOWN ·Phase: NA
-
Thymic Stromal Lymphopoietin (TSLP) in Vitiligo
NCT03367273 ·Status: COMPLETED ·Phase: NA
-
Sensory Symptoms in Active Vitiligo
NCT05390164 ·Status: UNKNOWN
-
Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles
NCT07298551 ·Status: NOT_YET_RECRUITING
-
Vitiligo, New Treatment and Serum s100B
NCT06768840 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Leucotrichia in Vitiligo
NCT03402633 ·Status: COMPLETED
-
Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo
NCT04320160 ·Status: UNKNOWN ·Phase: NA
-
Human Beta-defensin 1 in Vitiligo
NCT03832751 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
NCT05525741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN
-
The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis
NCT00509314 ·Status: UNKNOWN
-
ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO
NCT05990309 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo
NCT05053022 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo
NCT05121532 ·Status: UNKNOWN ·Phase: NA
-
Resident Memory T Cells in Vitiligo
NCT05223738 ·Status: UNKNOWN
-
Photoprotection Habits in Patients With Vitiligo
NCT03323125 ·Status: COMPLETED
-
Epidermal Cell Transplantation in Vitiligo Skin
NCT01629979 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients
NCT06584643 ·Status: NOT_YET_RECRUITING
-
Janus Kinase 1 in Vitiligo & Psoriasis
NCT03762551 ·Status: COMPLETED ·Phase: NA
-
Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Stable Vitiligo
NCT06810869 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity
NCT03741738 ·Status: COMPLETED